Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis

OBJECTIVE: Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases with various subtypes, myositis-specific antibodies, and affect multiple systems. The treatment of IIMs remains challenging, especially for refractory myositis. In addition to steroids and tradition...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhen, Chao, Hou, Ying, Zhao, Bing, Ma, Xiaotian, Dai, Tingjun, Yan, Chuanzhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791086/
https://www.ncbi.nlm.nih.gov/pubmed/36578492
http://dx.doi.org/10.3389/fimmu.2022.1051609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791086/
https://www.ncbi.nlm.nih.gov/pubmed/36578492
http://dx.doi.org/10.3389/fimmu.2022.1051609

Ejemplares similares